SRRK Covered Call Strategy
SRRK (Scholar Rock Holding Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
SRRK (Scholar Rock Holding Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.56B, a beta of 0.70 versus the broader market, a 52-week range of 27.07-55.19, average daily share volume of 1.5M, a public-listing history dating back to 2018, approximately 128 full-time employees. These structural characteristics shape how SRRK stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.70 indicates SRRK has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on SRRK?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current SRRK snapshot
As of June 29, 2026, spot at $54.61, ATM IV 58.10%, IV rank 13.08%, expected move 16.66%. The covered call on SRRK below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this covered call structure on SRRK specifically: SRRK IV at 58.10% is on the cheap side of its 1-year range, which means a premium-selling SRRK covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 16.66% (roughly $9.10 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SRRK expiries trade a higher absolute premium for lower per-day decay. Position sizing on SRRK should anchor to the underlying notional of $54.61 per share and to the trader's directional view on SRRK stock.
SRRK covered call setup
The SRRK covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SRRK near $54.61, the first option leg uses a $57.34 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SRRK chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SRRK shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $54.61 | long |
| Sell 1 | Call | $57.34 | N/A |
SRRK covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
SRRK covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on SRRK. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on SRRK
Covered calls on SRRK are an income strategy run on existing SRRK stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
SRRK thesis for this covered call
The market-implied 1-standard-deviation range for SRRK extends from approximately $45.51 on the downside to $63.71 on the upside. A SRRK covered call collects premium on an existing long SRRK position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether SRRK will breach that level within the expiration window. Current SRRK IV rank near 13.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SRRK at 58.10%. As a Healthcare name, SRRK options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SRRK-specific events.
SRRK covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SRRK positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SRRK alongside the broader basket even when SRRK-specific fundamentals are unchanged. Short-premium structures like a covered call on SRRK carry tail risk when realized volatility exceeds the implied move; review historical SRRK earnings reactions and macro stress periods before sizing. Always rebuild the position from current SRRK chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on SRRK?
- A covered call on SRRK is the covered call strategy applied to SRRK (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With SRRK stock trading near $54.61, the strikes shown on this page are snapped to the nearest listed SRRK chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SRRK covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the SRRK covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 58.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SRRK covered call?
- The breakeven for the SRRK covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SRRK market-implied 1-standard-deviation expected move is approximately 16.66%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on SRRK?
- Covered calls on SRRK are an income strategy run on existing SRRK stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current SRRK implied volatility affect this covered call?
- SRRK ATM IV is at 58.10% with IV rank near 13.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.